-+ 0.00%
-+ 0.00%
-+ 0.00%

CULLINAN THERAPEUTICS SHARES NEW CLINICAL DATA ACROSS ITS PORTFOLIO OF T CELL ENGAGER PROGRAMS TARGETING CD19 AND BCMA IN AUTOIMMUNE DISEASES

Reuters·06/10/2026 11:30:48

Please log in to view news